Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML - November 01, 2021

PDF +
Supplementary
Material

XML

Basic tumor immunology

Original research

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

	Abstract	Full	Pdf
Jul 2021	127	127	38
Aug 2021	591	592	256
Sep 2021	247	247	123
Oct 2021	266	266	101
Nov 2021	158	158	69
Dec 2021	131	131	88
Jan 2022	112	116	62
Feb 2022	137	170	86
Mar 2022	160	168	84
Apr 2022	105	112	61
May 2022	87	88	49
Jun 2022	143	153	80
Jul 2022	82	87	52
Aug 2022	142	144	78
Sep 2022	150	154	79
Oct 2022	145	151	79
Nov 2022	145	146	76
Dec 2022	64	66	39
Jan 2023	125	125	40
Feb 2023	117	117	51
Mar 2023	91	92	80
Apr 2023	55	58	43
May 2023	78	81	51
Jun 2023	101	102	53
Jul 2023	68	68	38
Aug 2023	61	64	53
Sep 2023	75	75	59
Oct 2023	82	82	64
Nov 2023	78	78	37
Dec 2023	72	72	43
Jan 2024	57	58	28
Feb 2024	73	75	40
Mar 2024	138	140	92
Total	4263	4363	2272